The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Hemorrhagic Disorders

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Hemorrhagic Disorders


High impact information on Hemorrhagic Disorders


Chemical compound and disease context of Hemorrhagic Disorders


Biological context of Hemorrhagic Disorders


Anatomical context of Hemorrhagic Disorders

  • The patient displayed the typical features of APL including impaction of the marrow with promyelocytes, marked elevation of the serum vitamin B12 and transcobalamin I levels and a hemorrhagic diathesis [18].

Gene context of Hemorrhagic Disorders


  1. Annexin II and bleeding in acute promyelocytic leukemia. Menell, J.S., Cesarman, G.M., Jacovina, A.T., McLaughlin, M.A., Lev, E.A., Hajjar, K.A. N. Engl. J. Med. (1999) [Pubmed]
  2. Hemorrhagic disorder due to an isoniazid-associated acquired factor XIII inhibitor in a patient with Waldenström's macroglobulinemia. Krumdieck, R., Shaw, D.R., Huang, S.T., Poon, M.C., Rustagi, P.K. Am. J. Med. (1991) [Pubmed]
  3. Trisomy 8p due to the 3:1 segregation of the balanced translocation t(8;15)mat. Lazjuk, G.I., Lurie, I.W., Usova, Y.I., Gurevich, D.B., Nedzved, M.K. Hum. Genet. (1979) [Pubmed]
  4. Immune thrombocytopenic purpura. Koller, C.A. Med. Clin. North Am. (1980) [Pubmed]
  5. rim2 (recombination-induced mutation 2) is a new allele of pearl and a mouse model of human Hermansky-Pudlak syndrome (HPS): genetic and physical mapping. Sagai, T., Koide, T., Endo, M., Tanoue, K., Kikkawa, Y., Yonekawa, H., Ishiguro, S., Tamai, M., Matsuda, Y., Wakana, S., Shiroishi, T. Mamm. Genome (1998) [Pubmed]
  6. Characterization of an acquired inhibitor to coagulation factor V. Antibody binding to the second C-type domain of factor V inhibits the binding of factor V to phosphatidylserine and neutralizes procoagulant activity. Ortel, T.L., Quinn-Allen, M.A., Charles, L.A., Devore-Carter, D., Kane, W.H. J. Clin. Invest. (1992) [Pubmed]
  7. alpha 2-Antiplasmin Enschede: dysfunctional alpha 2-antiplasmin molecule associated with an autosomal recessive hemorrhagic disorder. Kluft, C., Nieuwenhuis, H.K., Rijken, D.C., Groeneveld, E., Wijngaards, G., van Berkel, W., Dooijewaard, G., Sixma, J.J. J. Clin. Invest. (1987) [Pubmed]
  8. Factor XIII. Kitchens, C.S., Newcomb, T.F. Medicine (Baltimore) (1979) [Pubmed]
  9. Daunorubicin and platelet function. Pogliani, E.M., Fantasia, R., Lambertenghi-Deliliers, G., Cofrancesco, E. Thromb. Haemost. (1981) [Pubmed]
  10. Platelet-associated immunoglobulin G in childhood idiopathic thrombocytopenic purpura. Lightsey, A.L., Koenig, H.M., McMillan, R., Stone, J.R. J. Pediatr. (1979) [Pubmed]
  11. V2 receptor antagonism of DDAVP-induced release of hemostasis factors in conscious dogs. Bernat, A., Hoffmann, P., Dumas, A., Serradeil-le Gal, C., Raufaste, D., Herbert, J.M. J. Pharmacol. Exp. Ther. (1997) [Pubmed]
  12. Cardiopulmonary bypass for patients with previously documented heparin-induced platelet aggregation. Olinger, G.N., Hussey, C.V., Olive, J.A., Malik, M.I. J. Thorac. Cardiovasc. Surg. (1984) [Pubmed]
  13. New beta-lactam antibiotics and hemorrhagic diathesis: comparison of moxalactam and cefotaxime. Andrassy, K., Koderisch, J., Fritz, S., Ritz, E. Clinical therapeutics. (1983) [Pubmed]
  14. Characterization of a myeloma patient with a life-threatening hemorrhagic diathesis: presence of a lambda dimer protein inhibiting shear-induced platelet aggregation by binding to the A1 domain of von Willebrand factor. Shinagawa, A., Kojima, H., Berndt, M.C., Kaneko, S., Suzukawa, K., Hasegawa, Y., Shigeta, O., Nagasawa, T. Thromb. Haemost. (2005) [Pubmed]
  15. Pregnancy outcome after maternal poisoning with brodifacoum, a long-acting warfarin-like rodenticide. Zurawski, J.M., Kelly, E.A. Obstetrics and gynecology. (1997) [Pubmed]
  16. A case of Weil's disease requiring steroid therapy for thrombocytopenia and bleeding. Kahn, J.B. Am. J. Trop. Med. Hyg. (1982) [Pubmed]
  17. Pathoanatomical features of the kidney in myelomonocytic and chronic lymphocytic leukemia. Schwarze, E.W. Virchows Archiv. A, Pathological anatomy and histology. (1975) [Pubmed]
  18. Acute promyelocytic leukemia in childhood. Report of a case with a review of the literature. Engelhard, D., Yatziv, S., Rachmilewitz, E.A., Polliack, A. Acta Haematol. (1979) [Pubmed]
  19. Hereditary alpha 2-plasmin inhibitor deficiency caused by a transport-deficient mutation (alpha 2-PI-Okinawa). Deletion of Glu137 by a trinucleotide deletion blocks intracellular transport. Miura, O., Sugahara, Y., Aoki, N. J. Biol. Chem. (1989) [Pubmed]
  20. Real-time quantitative PCR analysis of factor XI mRNA variants in human platelets. Podmore, A., Smith, M., Savidge, G., Alhaq, A. J. Thromb. Haemost. (2004) [Pubmed]
  21. Carrier detection and prenatal diagnosis of hemophilia in developing countries. Peyvandi, F. Semin. Thromb. Hemost. (2005) [Pubmed]
  22. Albinism and Hermansky-Pudlak syndrome in Puerto Rico. Witkop, C.J., Nuñez Babcock, M., Rao, G.H., Gaudier, F., Summers, C.G., Shanahan, F., Harmon, K.R., Townsend, D., Sedano, H.O., King, R.A. Boletín de la Asociación Médica de Puerto Rico. (1990) [Pubmed]
  23. Thromboembolism in Hageman trait. McPherson, R.A. Am. J. Clin. Pathol. (1977) [Pubmed]
WikiGenes - Universities